Literature DB >> 6823859

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.

M M Applefeld, K A Newman, W R Grove, F J Sutton, D S Roffman, W P Reed, S E Linberg.   

Abstract

The use of outpatient dobutamine infusions by a small, portable infusion pump in 3 patients with intractable congestive heart failure (CHF) is described. With this therapy left ventricular function improved and CHF resolved in each. Tolerance to dobutamine was obviated by giving infusions twice weekly. Except for 3 mild infections around the catheter exit site, there have been no complications of this therapy is 58 cumulative patient weeks.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823859     DOI: 10.1016/s0002-9149(83)80079-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Modern treatment of heart failure.

Authors:  A D Timmis
Journal:  BMJ       Date:  1988-07-09

2.  Long-term dobutamine in heart failure.

Authors:  M Gorrie; A Nicholls
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

3.  Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.

Authors:  H H Erlemeier; W Kupper; W Bleifeld
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

4.  Hemodynamic effects of prolonged enoximone infusion (7 days) in patients with severe chronic heart failure.

Authors:  P Gibelin; M Dadoun-Dybal; M Candito; J F Robillon; P Morand
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 5.  Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions.

Authors:  K T Weber; S K Gill; J S Janicki; C S Maskin; M C Jain
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

6.  Pharmacology and inotropic potential of forskolin in the human heart.

Authors:  M R Bristow; R Ginsburg; A Strosberg; W Montgomery; W Minobe
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.